Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 9 October 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease...